98%
921
2 minutes
20
Background: Primary dysmenorrhea (PD) is a common gynecological disease characterized by lower abdominal pain. Moxibustion as a traditional Chinese treatment, can effectively treat PD with few adverse reactions. Nowadays, there is still no standard guideline for moxibustion treatment of PD, so related clinical practice guidelines need to be developed.
Methods: This guideline will be developed in line with the latest guideline definition from Institute of Medicine, and that applies the GRADE system as well as the World Health Organization handbook to appraise the quality of evidence and develop recommendations. We will set up a Guideline working group, put forward the corresponding problems based on the principle of Population, Intervention, Comparison, Outcomes (PICO), and complete the literature retrieval. After achieving consensus through evidence syntheses and 2 to 3 rounds of Delphi process, we will also consider patients values and preferences and implement peer review in the guideline.
Result: We will put forward evidence-based best practice recommendations and moxibustion standard to improve the symptoms caused by primary dysmenorrhea in a more efficient way. At present, the research is still in progress, and there is no result to report.
Conclusions: This guideline will be helpful to clinical acupuncturists and other professionals to further improve clinical efficacy in treating PD with moxibustion. Moreover, we will also constantly update and evaluate the evidence to both support recommendations and identify gap areas for future research.
Systematic Review Registrations: registration number: IPGRP-2020CN021.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899813 | PMC |
http://dx.doi.org/10.1097/MD.0000000000024466 | DOI Listing |
J Ethnopharmacol
September 2025
The First Hospital of Hunan University of Chinese Medicine, Changsha 410007, China; Key Laboratory of Research and Transformation on Prevention and Treatment of Major Diseases in Internal Medicine of Traditional Chinese Medicine, Ministry of Education, Changsha 410007, China. Electronic address: mic
Ethnopharmacological Relevance: Primary dysmenorrhea (PD) is common and has a major impact on women's daily activities and quality of life. Wenjing Decoction (WD), a classic Chinese medicine formula, has been widely used for thousands of years in China to treat PD. However, the key pharmacodynamic substances in WD responsible for its anti-dysmenorrhea efficacy are still unclear.
View Article and Find Full Text PDFTidsskr Nor Laegeforen
September 2025
Senter for fruktbarhet og helse, Folkehelseinstituttet, og, Institutt for global helse og samfunnsmedisin, Universitetet i Bergen.
Background: The prevalence of endometriosis and adenomyosis in the Norwegian population is unknown. The aim of this study was to report on diagnoses of endometriosis, adenomyosis and related health problems among women of reproductive age.
Material And Method: We extracted specialist healthcare records of endometriosis and adenomyosis from the Norwegian Patient Registry for women aged 15 to 49 registered in Norway's National Population Register, covering the period 1 January 2008 to 31 December 2021.
Integr Med Res
March 2026
Department of Obstetrics and Gynecology, Dongguk University Ilsan Korean Medicine Hospital, Goyang, South Korea.
Background: This study aimed to evaluate the effectiveness and safety of individually prescribed decoction herbal medicine for the treatment of dysmenorrhea. Herbal decoction was compared to other herbal formulations and combined treatment modalities, focusing on reductions in menstrual pain intensity, duration, and analgesic use. Personalized herbal treatments were hypothesized to alleviate symptoms more effectively by addressing individual constitutional imbalances.
View Article and Find Full Text PDFYakugaku Zasshi
September 2025
Kampo Research Laboratories, Pharmaceutical Company, Kracie, Ltd.
Dysmenorrhea refers to pathological symptoms that occur in association with menstruation during the menstrual period. Treatment options for dysmenorrhea include nonsteroidal anti-inflammatory drugs (NSAIDs) and low-dose estrogen-progestin combination pills. However, some patients do not respond to these treatments, and long-term use can lead to adverse reactions, raising additional problems.
View Article and Find Full Text PDFLancet Child Adolesc Health
August 2025
Nuffield Department of Women's and Reproductive Health, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Background: Dysmenorrhoea affects many adolescents and often goes untreated for various sociocultural reasons. Dysmenorrhoea frequently co-occurs with other chronic pain conditions, and adult women with dysmenorrhoea have greater sensory sensitivity compared with controls. We aimed to test the hypothesis that adolescent dysmenorrhoea leads to the development of general chronic pain, including pain outside the pelvis, by estimating the risk of chronic pain in adulthood following the experience of dysmenorrhoea at age 15 years.
View Article and Find Full Text PDF